$2.57
Price
$308M
Market Cap
—
P/E Ratio
-2.6
Forward P/E
$-1.05
EPS (TTM)
—
Dividend Yield
$154M
Cash
$78M
Total Debt
120M
Shares Out
$0.93
$3.23
52-Week Range
Institutional Ownership of Fate Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Fate Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2021-Q4 | |||||
| SELL | EXIT | — | — | $56.51 | |
| 2021-Q1 | |||||
| BUY | +98.0% | 1.7M | $144M | $95.69 | |
| 2020-Q4 | |||||
| BUY | NEW | 883.7K | $80M | $51.98 | |
Insider Trading for Fate Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.